Finally, total agreement was also expressed regarding the ATA-R #15 which indicates to treat MEN 2B patients harboring codon 804 mutation associated to another mutation similarly to those with the more typical MEN 2B RET causing mutations. Here, RET is linked to multiple endocrine neoplasia type 2B.